The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 22.21

Cancer of the Pancreas (Invasive)

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2016
By Race/Ethnicity, Sex and Years Since Diagnosis

Race/Ethnicity Sex Years Since Diagnosis Completee
0 to <5 5 to <10 10 to <15 15 to <20 20 to <24 0 to <24b >=24d
All Races Both Sexes 53,929 10,127 4,024 1,824 832 70,735 2,819 73,554
Males 27,124 5,187 1,759 810 208 35,088 1,330 36,418
Females 26,805 4,940 2,265 1,014 623 35,647 1,489 37,136
White Both Sexes 44,556 8,296 3,377 1,411 655 58,294 2,308 61,221
Males 22,760 4,311 1,562 690 172 29,495 1,163 31,041
Females 21,796 3,985 1,814 721 482 28,799 1,145 30,180
Black Both Sexes 6,478 1,238 411 260 89 8,476 881 9,358
Males 2,875 583 108 76 0 3,642 406 4,048
Females 3,602 655 303 185 89 4,834 475 5,309
Asian/
Pacific
Islander		 Both Sexes 2,167 415 185 87 34 2,889 + +
Males 1,038 200 67 24 10 1,339 + +
Females 1,129 215 118 63 25 1,550 + +
Hispanic Both Sexes 4,279 724 362 177 96 5,638 + +
Males 1,873 332 121 67 6 2,400 + +
Females 2,406 392 241 110 89 3,238 + +

Estimated prevalence percent a on January 1, 2016, of the SEER population diagnosed in the previous 24 years
By Age at Prevalence, Race/Ethnicity and Sex

Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedc
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races Both Sexes 0.0220 0.0000 0.0003 0.0010 0.0029 0.0095 0.0272 0.0613 0.0992 0.0938 0.0186
Males 0.0221 0.0000 0.0003 0.0005 0.0025 0.0085 0.0269 0.0682 0.1132 0.1093 0.0201
Females 0.0218 0.0001 0.0003 0.0015 0.0034 0.0105 0.0274 0.0551 0.0876 0.0842 0.0174
White Both Sexes 0.0231 0.0001 0.0003 0.0011 0.0029 0.0091 0.0257 0.0604 0.1002 0.0940 0.0184
Males 0.0236 0.0001 0.0002 0.0006 0.0025 0.0081 0.0261 0.0674 0.1148 0.1103 0.0200
Females 0.0226 0.0001 0.0003 0.0016 0.0034 0.0101 0.0253 0.0539 0.0878 0.0838 0.0171
Black Both Sexes 0.0188 - 0.0003 0.0007 0.0024 0.0123 0.0374 0.0721 0.0961 0.0891 0.0204
Males 0.0168 - 0.0003 0.0005 0.0017 0.0105 0.0331 0.0791 0.0999 0.0904 0.0203
Females 0.0206 - 0.0003 0.0009 0.0030 0.0139 0.0412 0.0666 0.0934 0.0885 0.0206
Asian/
Pacific
Islander		 Both Sexes 0.0142 - - 0.0008 0.0037 0.0077 0.0209 0.0502 0.0759 0.0791 0.0151
Males 0.0137 - - - 0.0036 0.0083 0.0194 0.0512 0.0906 0.0812 0.0159
Females 0.0146 - - 0.0013 0.0038 0.0072 0.0221 0.0494 0.0642 0.0777 0.0144
Hispanic Both Sexes 0.0099 0.0001 0.0003 0.0011 0.0027 0.0076 0.0203 0.0467 0.0812 0.0836 0.0151
Males 0.0083 - 0.0004 0.0003 0.0014 0.0057 0.0177 0.0449 0.0958 0.0717 0.0147
Females 0.0115 0.0001 0.0003 0.0020 0.0041 0.0095 0.0229 0.0482 0.0700 0.0909 0.0157

Footnotes:

a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the Alaska Native Registry) and 1/1/2016 US population estimates based on the average of 2015 and 2016 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years.

b Maximum limited-duration prevalence is 24 years for 1992-2016 data.

c Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

d Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

e Complete prevalence is obtained by summing 0 to <24 and >=24.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.